Ischiorectal Fossa Tumors: Thirty-Year Single Institution Experience

Thomas Peponis,William R.G. Perry,Scott R. Kelley
DOI: https://doi.org/10.1097/dcr.0000000000003255
2024-04-16
Diseases of the Colon & Rectum
Abstract:BACKGROUND: Primary tumors of the ischiorectal fossa are rare and comprise a wide array of pathologies with varying malignant potential. Due to the low prevalence, there is a paucity of data in the literature. This paper presents a case-series on the management of ischiorectal fossa tumors. OBJECTIVE: To present a 30-year experience managing ischiorectal fossa tumors. DESIGN: Retrospective single center analysis. SETTINGS: A quaternary referral academic healthcare center. PATIENTS: All patients treated for ischiorectal fossa tumors. INTERVENTIONS: All patients underwent surgical management of their disease. MAIN OUTCOME MEASURES: Disease recurrence and overall survival. RESULTS: A total of 34 patients (53% female) were identified with a median follow-up of 23 months. Twenty-one patients (62%) were diagnosed with benign and 13 (38%) with malignant tumors. All underwent surgical resection. Median tumor size was 8.4 cm. R0 resection was obtained in 28 patients. Twelve (35%) developed recurrence (nine following R0 resection) with a median time of 6.5 months. There were no surgical related mortalities. LIMITATIONS: Limitations to the study include its retrospective nature, single center experience, and small patient sample size. CONCLUSIONS: Ischiorectal fossa tumors are primarily benign, however they are associated with high recurrence rates even in the setting of an R0 resection. Treatment should be approached in a multidisciplinary fashion and preferably in centers with experience treating these tumors. Close post treatment surveillance is imperative. See Video Abstract .
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?